Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEADER-PAD
NCT04774159Phase 3Recruiting
- Sponsor
- Population Health Research Institute
- Start
- May 2021
- Primary completion
- Dec 2029
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 10
01
Overview
A Phase 3 trial of colchicine in peripheral artery disease (PAD), sponsored by Population Health Research Institute. Started May 2021; status: recruiting.
02
Drugs
colchicine
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT04774159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04774159.